[1] 于凯. 显微镜下经单鼻孔蝶窦入路微创手术切除垂体瘤的效果分析[J].中国医药指南, 2016, 14(17):47.
[2] Robertson AM, Heaney AP. Molecular markers in pituitary tumors[J].Curr Opin Endocrinol Diabetes Obes,2016, 23(4):324.
[3] Singh H, Essayed WI, Cohengadol A,et al. Resection of pituitary tumors: endoscopic versus microscopic[J].J Neurooncol,2016, 130(2):1-9.
[4] Asa SL, Ezzat S. Aggressive pituitary tumors or localized pituitary carcinomas: defining pituitary tumors[J].Expert Rev Endocrinol Metab,2016, 11(2):89-91.
[5] 李舜, 唐晓平, 张柳,等. 神经内镜与显微镜在单鼻孔蝶窦入路切除垂体瘤患者中的疗效及并发症观察[J].中国实用神经疾病杂志, 2017, 20(7):15-18.
[6] 胡彦兵, 潘红波, 唐献江. 神经内镜下经单鼻孔蝶窦入路垂体瘤切除术治疗垂体腺瘤疗效分析[J].中国实用神经疾病杂志, 2016, 19(15):108-109.
[7] Bolger GB, Bizzi MF, Pinheiro SV, et al. cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors[J].Endocrine-related cancer,2016, 23(5):419.
[8] Martinez-Barbera JP, Andoniadou CL. Concise review: paracrine role of stem cells in pituitary tumors: a focus on adamantinomatous craniopharyngioma[J].Stem Cells,2016, 34(2):268-276.
[9] 吴永刚, 张诚, 黄啸元,等. 神经内镜引导下经鼻蝶窦入路切除垂体瘤的临床研究[J].临床与病理杂志, 2016, 36(7):951-955.
[10] Bastos RV, Silva CM, Tagliarini JV, et al. Endoscopic versus microscopic transsphenoidal surgery in the treatment of pituitary tumors: systematic review and meta-analysis of randomized and non-randomized controlled trials.
[J].Arch Endocrinol Metab,2016, 60(5):411-419. |
2018, Vol. 35 
